Noradrenergic suppression to reduce electroencephalographic arousal after intubation: a randomised, placebo-controlled trial
Background: Intraoperative awareness, without explicit recall, occurs after induction of anaesthesia in approximately 10% of persons under 40 yr of age. Most anaesthetic agents minimally suppress the noradrenergic system. We hypothesised that addition of dexmedetomidine, which suppresses noradrenerg...
Saved in:
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-03-01
|
| Series: | BJA Open |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2772609624001096 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850047799046963200 |
|---|---|
| author | Kaitlin Kramer Thomas Payne Mitchell Brooks Jessica Barry Neha Mahajan Samantha Malcolm Hannah Braithwaite Alex Wang Chris Thompson Keith Liyanagama Robert D. Sanders |
| author_facet | Kaitlin Kramer Thomas Payne Mitchell Brooks Jessica Barry Neha Mahajan Samantha Malcolm Hannah Braithwaite Alex Wang Chris Thompson Keith Liyanagama Robert D. Sanders |
| author_sort | Kaitlin Kramer |
| collection | DOAJ |
| description | Background: Intraoperative awareness, without explicit recall, occurs after induction of anaesthesia in approximately 10% of persons under 40 yr of age. Most anaesthetic agents minimally suppress the noradrenergic system. We hypothesised that addition of dexmedetomidine, which suppresses noradrenergic activity, may reduce encephalographic (EEG) arousal in response to tracheal intubation; such an effect would lay the foundation for future studies of dexmedetomidine in reducing intraoperative awareness. Methods: A single-site randomised, placebo-controlled trial with sex-based stratification was conducted. Participants, aged 18–40 yr old, undergoing intubation for general anaesthesia were eligible for recruitment and randomly allocated to receive dexmedetomidine or placebo. Dexmedetomidine (0.5 μg kg−1) was given as a 5-min loading dose before induction. Bispectral index (BIS) values were collected during the induction phase of anaesthesia and the isolated forearm technique was used to assess patients' responsiveness before and after tracheal intubation. The primary outcome was the effect of dexmedetomidine on changes in BIS from pre-to postintubation. Results: A total of 51 patients were recruited and included in the primary analysis. We did not observe an effect of dexmedetomidine on changes in BIS after tracheal intubation (mean difference –1.13, 95% confidence interval [CI] –4.87 to 2.62; p=0.556). Dexmedetomidine reduced the estimated plasma propofol concentration at loss of responsiveness (difference [dexmedetomidine – placebo]: –1.06 μg ml−1, 95% CI –1.66 to –0.46; p<0.001) and before intubation (difference [dexmedetomidine – placebo]: –1.84 μg ml−1, 95% CI –2.79 to –0.90; p<0.001). There was one patient in the placebo group who gave positive responses in the isolated forearm test before and after tracheal intubation. Conclusions: Dexmedetomidine demonstrated an anaesthetic-sparing effect at induction of anaesthesia but did not prevent EEG arousal after tracheal intubation, as defined by an increase in the BIS value. Clinical Trial Registration: Australia and New Zealand Clinical Trials Registry (Trial ID: ACTRN12622000754741). |
| format | Article |
| id | doaj-art-76989d87cace43fd8a79e28a71932434 |
| institution | DOAJ |
| issn | 2772-6096 |
| language | English |
| publishDate | 2025-03-01 |
| publisher | Elsevier |
| record_format | Article |
| series | BJA Open |
| spelling | doaj-art-76989d87cace43fd8a79e28a719324342025-08-20T02:54:07ZengElsevierBJA Open2772-60962025-03-011310035910.1016/j.bjao.2024.100359Noradrenergic suppression to reduce electroencephalographic arousal after intubation: a randomised, placebo-controlled trialKaitlin Kramer0Thomas Payne1Mitchell Brooks2Jessica Barry3Neha Mahajan4Samantha Malcolm5Hannah Braithwaite6Alex Wang7Chris Thompson8Keith Liyanagama9Robert D. Sanders10Department of Anaesthetics, Royal Prince Alfred Hospital, Sydney, NSW, Australia; Faculty of Medicine and Health, University of Sydney, Sydney, NSW, AustraliaFaculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia; The Royal Melbourne Hospital, Melbourne, VIC, AustraliaDepartment of Anaesthetics, Royal Prince Alfred Hospital, Sydney, NSW, AustraliaDepartment of Anaesthetics, Royal Prince Alfred Hospital, Sydney, NSW, AustraliaDepartment of Anaesthetics, Royal Prince Alfred Hospital, Sydney, NSW, AustraliaDepartment of Anaesthetics, Royal Prince Alfred Hospital, Sydney, NSW, AustraliaDepartment of Anaesthetics, Royal Prince Alfred Hospital, Sydney, NSW, AustraliaDepartment of Anaesthetics, Royal Prince Alfred Hospital, Sydney, NSW, AustraliaDepartment of Anaesthetics, Royal Prince Alfred Hospital, Sydney, NSW, AustraliaDepartment of Anaesthetics, Royal Prince Alfred Hospital, Sydney, NSW, AustraliaDepartment of Anaesthetics, Royal Prince Alfred Hospital, Sydney, NSW, Australia; Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia; Corresponding author.Background: Intraoperative awareness, without explicit recall, occurs after induction of anaesthesia in approximately 10% of persons under 40 yr of age. Most anaesthetic agents minimally suppress the noradrenergic system. We hypothesised that addition of dexmedetomidine, which suppresses noradrenergic activity, may reduce encephalographic (EEG) arousal in response to tracheal intubation; such an effect would lay the foundation for future studies of dexmedetomidine in reducing intraoperative awareness. Methods: A single-site randomised, placebo-controlled trial with sex-based stratification was conducted. Participants, aged 18–40 yr old, undergoing intubation for general anaesthesia were eligible for recruitment and randomly allocated to receive dexmedetomidine or placebo. Dexmedetomidine (0.5 μg kg−1) was given as a 5-min loading dose before induction. Bispectral index (BIS) values were collected during the induction phase of anaesthesia and the isolated forearm technique was used to assess patients' responsiveness before and after tracheal intubation. The primary outcome was the effect of dexmedetomidine on changes in BIS from pre-to postintubation. Results: A total of 51 patients were recruited and included in the primary analysis. We did not observe an effect of dexmedetomidine on changes in BIS after tracheal intubation (mean difference –1.13, 95% confidence interval [CI] –4.87 to 2.62; p=0.556). Dexmedetomidine reduced the estimated plasma propofol concentration at loss of responsiveness (difference [dexmedetomidine – placebo]: –1.06 μg ml−1, 95% CI –1.66 to –0.46; p<0.001) and before intubation (difference [dexmedetomidine – placebo]: –1.84 μg ml−1, 95% CI –2.79 to –0.90; p<0.001). There was one patient in the placebo group who gave positive responses in the isolated forearm test before and after tracheal intubation. Conclusions: Dexmedetomidine demonstrated an anaesthetic-sparing effect at induction of anaesthesia but did not prevent EEG arousal after tracheal intubation, as defined by an increase in the BIS value. Clinical Trial Registration: Australia and New Zealand Clinical Trials Registry (Trial ID: ACTRN12622000754741).http://www.sciencedirect.com/science/article/pii/S2772609624001096accidental awareness under general anaesthesiaanaesthesiaconnected consciousnessdexmedetomidinesurgery |
| spellingShingle | Kaitlin Kramer Thomas Payne Mitchell Brooks Jessica Barry Neha Mahajan Samantha Malcolm Hannah Braithwaite Alex Wang Chris Thompson Keith Liyanagama Robert D. Sanders Noradrenergic suppression to reduce electroencephalographic arousal after intubation: a randomised, placebo-controlled trial BJA Open accidental awareness under general anaesthesia anaesthesia connected consciousness dexmedetomidine surgery |
| title | Noradrenergic suppression to reduce electroencephalographic arousal after intubation: a randomised, placebo-controlled trial |
| title_full | Noradrenergic suppression to reduce electroencephalographic arousal after intubation: a randomised, placebo-controlled trial |
| title_fullStr | Noradrenergic suppression to reduce electroencephalographic arousal after intubation: a randomised, placebo-controlled trial |
| title_full_unstemmed | Noradrenergic suppression to reduce electroencephalographic arousal after intubation: a randomised, placebo-controlled trial |
| title_short | Noradrenergic suppression to reduce electroencephalographic arousal after intubation: a randomised, placebo-controlled trial |
| title_sort | noradrenergic suppression to reduce electroencephalographic arousal after intubation a randomised placebo controlled trial |
| topic | accidental awareness under general anaesthesia anaesthesia connected consciousness dexmedetomidine surgery |
| url | http://www.sciencedirect.com/science/article/pii/S2772609624001096 |
| work_keys_str_mv | AT kaitlinkramer noradrenergicsuppressiontoreduceelectroencephalographicarousalafterintubationarandomisedplacebocontrolledtrial AT thomaspayne noradrenergicsuppressiontoreduceelectroencephalographicarousalafterintubationarandomisedplacebocontrolledtrial AT mitchellbrooks noradrenergicsuppressiontoreduceelectroencephalographicarousalafterintubationarandomisedplacebocontrolledtrial AT jessicabarry noradrenergicsuppressiontoreduceelectroencephalographicarousalafterintubationarandomisedplacebocontrolledtrial AT nehamahajan noradrenergicsuppressiontoreduceelectroencephalographicarousalafterintubationarandomisedplacebocontrolledtrial AT samanthamalcolm noradrenergicsuppressiontoreduceelectroencephalographicarousalafterintubationarandomisedplacebocontrolledtrial AT hannahbraithwaite noradrenergicsuppressiontoreduceelectroencephalographicarousalafterintubationarandomisedplacebocontrolledtrial AT alexwang noradrenergicsuppressiontoreduceelectroencephalographicarousalafterintubationarandomisedplacebocontrolledtrial AT christhompson noradrenergicsuppressiontoreduceelectroencephalographicarousalafterintubationarandomisedplacebocontrolledtrial AT keithliyanagama noradrenergicsuppressiontoreduceelectroencephalographicarousalafterintubationarandomisedplacebocontrolledtrial AT robertdsanders noradrenergicsuppressiontoreduceelectroencephalographicarousalafterintubationarandomisedplacebocontrolledtrial |